By contrast, NTRK2 fusions more exclusively exist in central nervous system (CNS) tumors like gliomas, according to a study where NTRK2 fusion was detected in most NTRK fusion-positive patients (9/14) (18, 29). This evidence concerns the gene NTRK2 and glioma.